December 15th, 2015

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biogen, Inc. (NQ: BIIB )

275.54 USD +6.10 (+2.26%)
Official Closing Price Updated: 7:54 PM EST, Jan 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Biogen, Inc.

< Previous 1 2
...
46 47 48 49 50 51 52 53 54
...
57 58 Next >
Biogen Idec to Present at the Deutsche Bank 34th Annual Health Care Conference
From Business Wire News Releases
WallStSense.com Free Research Report for Shareholders of BRE, CPN, CPT and BIIB
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by WallStSense.com 
From Marketwired News Releases
First Ten-Year Follow-Up Shows That Treatment with AVONEX® Leads to Long-Term Benefits in Early Multiple Sclerosis Patients
From Business Wire News Releases
MRI Data Showing TYSABRI® Promoted Remyelination Presented at the 61st Annual Meeting of the American Academy of Neurology
From Business Wire News Releases
Biogen Idec Board Recommends Shareholders Elect Directors with Record of Success in Enhancing the Value of the Company
From Business Wire News Releases
Zacks Bull & Bear of the Day Highlights: Biogen Idec, Liberty Property Trust, BB&T, Goldman Sachs and JPMorgan Chase
From Business Wire News Releases
Biogen Idec Reports First Quarter 2009 Results
From Business Wire News Releases
Biogen Idec Receives Approval for TYSABRI® High Titer Production
From Business Wire News Releases
Biogen Idec Showcases Leading Multiple Sclerosis Franchise and Pipeline at the 61st Annual Meeting of the American Academy of Neurology
From Business Wire News Releases
Schaeffer's Option Activity Alert: High Hopes for Biogen Idec Inc. Ahead of Earnings
From Business Wire News Releases
AnalystChoice.com Free Investment Opinion on LKQX, JOSB, CRME and BIIB
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by AnalystChoice.com (AC). 
From Marketwired News Releases
Zenobia Therapeutics Successfully Completes Initial Phase of Its Service Agreement With Syntonix Pharmaceuticals
From PR Newswire
Biogen Idec to Report First Quarter 2009 Financial Results on April 16, 2009
From Business Wire News Releases
PennyPic Daily Report Alerts Subscribers on Market Movers: CSCO, ORCL, BIIB, GE, F, BAC
From PR Newswire
Biogen Idec to Present at the 4(th) Annual Citi Biotech Day
From Business Wire News Releases
Biogen Idec Names Robert Hamm Chief Operating Officer
From Business Wire News Releases
Biogen Idec Highlights Progress and Breadth of Pipeline Programs at R&D Day
From Business Wire News Releases
AVEO and Biogen Idec Form Strategic Alliance for Development and Commercialization of ErbB3-Targeted Antibodies
From Business Wire News Releases
AnalystChoice.com Free CFA Opinion on SWK, APOL, ZION and BIIB
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by AnalystChoice.com (AC). 
From Marketwired News Releases
Biogen Idec Announces March 25 Webcast of Research & Development Day
From Business Wire News Releases
Biogen Idec Announces Head of Research and Development Dr. Cecil B. Pickett to Retire
From Business Wire News Releases
Phase III Study of Rituxan in Lupus Nephritis Did Not Meet Primary Endpoint
From Business Wire News Releases
Biogen Idec to Present at the Cowen & Company 29th Annual Healthcare Conference
From Business Wire News Releases
XplosiveStocks.com: ONXX, FSLR, ASTE, AAPL, ESRX, BIIB Hot Stock Alerts!
From PR Newswire
Biogen Idec Names Michael Lytton Executive Vice President of Business Development
From Business Wire News Releases
Zacks Analyst Blog Highlights: Biogen Idec, Ford Motor Company, Tata Motors, United Parcel Service, Inc. and Carmike Cinemas, Inc.
From Business Wire News Releases
Zacks Bull & Bear of the Day Highlights: Biogen Idec, CEMEX, Ford, Tata Motors and Carmike Cinemas
From Business Wire News Releases
MS Patients Treated with TYSABRI® Remain Free of Disease Activity for Two Years, According to Data Published in the Lancet Neurology
From Business Wire News Releases
Beacon Equity Issues Trade Alerts on Newsworthy Market Movers: BIIB, TM, PBI, ESLR, TE, AOC
From PR Newswire
BenchmarkJournal.com (Complimentary) Analyst Review for NVLS, MCRS, BIIB and KFRC
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Benchmark Journal. 
From Marketwired News Releases
< Previous 1 2
...
46 47 48 49 50 51 52 53 54
...
57 58 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

More ways to get to us

Medicine Hat News Twitter Twitter
Medicine Hat News Facebook Facebook
Medicine Hat News YouTube YouTube
Medicine Hat News Tumblr Tumblr

About Us

Contact the Medicine Hat News

3257 Dunmore Rd SE
Medicine Hat, AB T1B 3R2

[P] 403.527.1101
[F] 403.528.5696

Print Advertising: 403.528.5650
National Advertising: 403.528.5766
Online Advertising: 403.528.5698
Classifieds: 403.526.7653

© 1996-2015 The Medicine Hat News, A Division of Continental Newspapers Canada Ltd.